The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

A public education session on the use of Narcan is being held 7 p.m. Tuesday at the \{a target=”_blank”\}Mansfield Public Library\{/a\}, 255 Hope St. Narcan is used to combat drug ...

If approved, the nasal spray formulation would provide an additional ... A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application.

9NEWS Medical Expert Dr. Payal Kohli weighs in on a new nasal spray being used to treat depression. 14 Outdated Home Trends That Are Lowering Your Property Value ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

State of Alaska Department of Revenue lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 1.6% in the fourth quarter, HoldingsChannel reports. The fund owned 21,325 ...